“I am passionate about bringing innovative therapeutic solutions to patients using advanced methods in applied mathematics, computational biology and machine learning.”
Your role at Institut Roche and brief presentation of your professional background:
I joined Institut Roche in 2021 as a postdoctoral researcher in computational biomedicine. In 2022, I joined the cancer immunology group at Genentech as a principal computational researcher. My role is to create computational tools that help develop new immune therapies for cancer patients and improve existing treatments.
My Focus at Institut Roche:
At Institut Roche, through my affiliation with Genentech, I strive to improve our understanding of T cell function in their interaction with cancer neoantigens. More specifically, I design computational tools to infer or predict how strong of an immune response a T cell receptor peptide-MHC pair triggers.